Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since May 14 · above the Ichimoku cloud · RSI 56 · MACD above its signal
| 21.89 | 52-week high | +11.23% |
| 20.90 | R3 (classic) | +6.20% |
| 20.46 | R2 (classic) | +3.96% |
| 20.26 | Previous week high | +2.95% |
| 20.07 | R1 (classic) | +1.98% |
| 20.02 | Previous day high | +1.73% |
| 19.72 | Previous month high | +0.20% |
| 19.68 | Price now | |
| 19.63 | Pivot | −0.25% |
| 19.24 | S1 (classic) | −2.24% |
| 19.19 | Previous day low | −2.49% |
| 19.19 | Previous week low | −2.49% |
| 18.80 | S2 (classic) | −4.47% |
| 18.41 | S3 (classic) | −6.45% |
| 17.82 | Previous month low | −9.45% |
| 11.48 | 52-week low | −41.67% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $719.7K | 0.00% | 44.10K | −91% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SIBN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
TimeframesUp on the daily and weekly, mixed on the hourly and monthly.
bouncing over the 21 EMA
over a rising 21 EMA, 21 over 50
over a rising 21 EMA, 21 over 50
bouncing over the 21 EMA
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.9 | -6.4 | -18.6 | -1.9 | 13.8 | 15.7 | 8.8 | 7.1 | -1.2 | 4.7 | −0.2% | ||
| 2025 | 19.5 | 8.1 | -22.6 | -2.7 | 38.5 | -0.4 | -9.5 | -2.1 | -11.7 | 0.7 | 31.2 | 1.3 | +40.7% |
| 2024 | -3.7 | -14.2 | -5.6 | -12.9 | -1.5 | -8.0 | 17.6 | 9.3 | -15.9 | -1.3 | -1.7 | 3.4 | −33.2% |
| 2023 | 25.2 | 16.1 | -0.5 | 12.4 | 13.9 | 7.1 | -4.5 | -11.2 | -7.2 | -19.9 | 11.5 | 10.7 | +54.3% |
| 2022 | -11.3 | 12.0 | 2.4 | -11.6 | -25.2 | -11.7 | 1.8 | 22.8 | 5.8 | 11.3 | -36.8 | 10.7 | −38.8% |
| 2021 | -2.1 | 7.2 | 1.3 | 11.6 | -15.0 | 4.3 | -3.6 | -19.5 | -12.2 | 5.3 | -14.6 | 15.4 | −25.7% |
| 2020 | -1.8 | -8.5 | -38.1 | 35.3 | 8.2 | -8.9 | 7.3 | 27.6 | 8.7 | -11.6 | 10.4 | 29.1 | +39.1% |
| 2019 | -13.9 | 15.2 | -9.1 | -9.8 | -1.2 | 21.1 | -11.6 | 8.1 | -9.1 | -5.8 | 6.8 | 20.9 | +2.9% |
| 2018 | -4.2 | 16.3 | +11.4% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 11, 2026 | Francis Laura A.Chief Executive Officer | Sale at price 20.05 per share. | 38K | $762.01K |
| Oct 4, 2026 | Maheshwari AnshulChief Operating Officer | Sale at price 18.17 - 19.50 per share. | 5K | $94.08K |
| Oct 1, 2026 | Pisetsky Michael AOfficer | Sale at price 18.14 - 18.20 per share. | 3.1K | $56.92K |
| Sep 30, 2026 | Dunn Jeffrey WDirector | Conversion of Exercise of derivative security at price 4.68 per share. | 20K | $93.60K |
| Sep 30, 2026 | Dunn Jeffrey WDirector | Sale at price 18.47 per share. | 20K | $369.40K |
| Aug 31, 2026 | Dunn Jeffrey WDirector | Conversion of Exercise of derivative security at price 4.68 per share. | 20K | $93.60K |
| Aug 31, 2026 | Dunn Jeffrey WDirector | Sale at price 18.91 per share. | 20K | $378.16K |
| Aug 23, 2026 | Maheshwari AnshulChief Financial Officer | Sale at price 20.11 per share. | 11.6K | $233.97K |
| Aug 23, 2026 | Francis Laura A.Chief Executive Officer | Sale at price 20.12 per share. | 26K | $522.60K |
| Aug 20, 2026 | Maheshwari AnshulChief Financial Officer | Sale at price 19.55 - 20.02 per share. | 17K | $337.14K |
| Aug 20, 2026 | Francis Laura A.Chief Executive Officer | Sale at price 19.46 - 20.02 per share. | 55.8K | $1.09M |
| Aug 16, 2026 | Pisetsky Michael AOfficer | Sale at price 18.62 - 18.65 per share. | 3.7K | $69.41K |
| Aug 16, 2026 | Maheshwari AnshulChief Financial Officer | Sale at price 18.62 - 18.68 per share. | 4.7K | $87.02K |
| Aug 16, 2026 | Francis Laura A.Chief Executive Officer | Sale at price 18.63 - 18.68 per share. | 15K | $279.06K |
| Aug 2, 2026 | Dunn Jeffrey WDirector | Conversion of Exercise of derivative security at price 4.68 per share. | 20K | $93.60K |
| Aug 2, 2026 | Dunn Jeffrey WDirector | Sale at price 18.46 per share. | 20K | $369.21K |
| Jul 1, 2026 | Pisetsky Michael AOfficer | Sale at price 16.70 - 16.86 per share. | 3.1K | $52.38K |
| Jul 1, 2026 | Maheshwari AnshulChief Financial Officer | Sale at price 16.73 - 16.80 per share. | 3.3K | $55.63K |
| Jun 4, 2026 | Dunn Jeffrey WDirector | Sale at price 15.25 per share. | 3.6K | $54.51K |
| Jun 3, 2026 | West Thomas ADirector | Stock Award(Grant) at price 0.00 per share. | 11K | — |
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Buy / hold / sell counts